Determination of 5α-androstane-3α,17β-diol and 5α-androstane-3β,17β-diol in human plasma by radioimmunoassay

Jacolot, F.; Adeline, J.; Berthou, F.; Floch, H.H.

doi:10.1016/0022-4731(85)90174-8

Cited by 5 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, no consistent sexual dimorphism has been demonstrated in the levels of plasma testosterone or DHT at these ages (11). Concentrations of 5␣-adiol were also higher in the pouch young than in a pool of adult male tammar plasma (0.6 ng⅐ml Ϫ1 ) in which the levels were similar to those in adult human males (17,18). We know of no other report that any circulating androgen has been shown to be sexually dimorphic in a mammal at the time of commencement of prostatic development.…”

Section: Resultsmentioning

confidence: 76%

Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol

Shaw

Renfree

Leihy

et al. 2000

Proc. Natl. Acad. Sci. U.S.A.

101

View full text Add to dashboard Cite

Development of the male urogenital tract in mammals is mediated by testicular androgens. It has been tacitly assumed that testosterone acts through its intracellular metabolite dihydrotestosterone (DHT) to mediate this process, but levels of these androgens are not sexually dimorphic in plasma at the time of prostate development. Here we show that the 3␣-reduced derivative of DHT, 5␣-androstane-3␣,17␤-diol (5␣-adiol), is formed in testes of tammar wallaby pouch young and is higher in male than in female plasma in this species during early sexual differentiation. Administration of 5␣-adiol caused formation of prostatic buds in female wallaby pouch young, and in tissue minces of urogenital sinus and urogenital tubercle radioactive 5␣-adiol was converted to DHT, suggesting that circulating 5␣-adiol acts through DHT in target tissues. We conclude that circulating 5␣-adiol is a key hormone in male development. I n all mammalian species testicular androgens control three aspects of male phenotypic development-conversion of the wolffian ducts into the epididymis, vas deferens, and seminal vesicles; formation of the male urethra and prostate; and formation of the phallus (1). Studies in animals and humans with mutations in the genes that encode the androgen receptor or steroid 5␣-reductase 2 indicate that testosterone virilizes the wolffian ducts and that 5␣-reduced androgens are essential for formation of the prostate and phallus (1). Because virilization occurs during early fetal development in eutherian mammals, it has not been possible to measure androgens in the circulation when virilization begins.Marsupial mammals offer an advantage for studying male phenotypic development, which takes place after birth when the young are easily accessible in the pouch and over a longer period than in the eutherian, so that it is possible to study the various aspects of phenotypic development individually (2). Virilization of the urogenital tract in the male marsupial pouch young is similar to that in eutherian fetuses, except that formation of the scrotum in marsupials is androgen-independent (2-6). This process has been examined in detail in one marsupial species, the tammar wallaby, Macropus eugenii, in which formation of the prostate begins in the urogenital sinus at around day 20 postpartum (5), whereas virilization of the penis commences around day 100 (6). Testosterone concentrations in the testes increase before prostate formation begins (7), and prostate development can be prevented by administration of the steroid 5␣-reductase inhibitor finasteride (8), which blocks the formation of dihydrotestosterone (DHT), or of the androgen receptor inhibitor flutamide (9), which prevents the actions of both testosterone and DHT. Administration of large amounts of testosterone (5) or transplantation of testes to female pouch young (10) causes prostate development, whereas castration of 10-day-old male pouch young prevents formation of the prostate and penis (10).Despite the wealth of evidence for a crucial role of 5␣-reduced androge...

show abstract

Section: Resultsmentioning

confidence: 76%

Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol

Shaw

Renfree

Leihy

et al. 2000

Proc. Natl. Acad. Sci. U.S.A.

101

View full text Add to dashboard Cite

show abstract

Determination of 5α-androstane-3α, 17β-diol and 5α-androstane-3β, 17β-diol in human plasma by selected ion monitoring

Jacolot

Picart

Berthou

et al. 1986

Biol. Mass Spectrom.

View full text Add to dashboard Cite

5 alpha-Androstane-3 alpha,17 beta-diol (3 alpha-diol) and 5 alpha-androstane-3 beta,17 beta-diol (3 beta-diol) were measured in human peripheral plasma by gas chromatography-selected ion monitoring as their t-butyl dimethylsilyl ethers. The purification of the plasma extract involved a Sep-Pak C18 cartridge and high-performance liquid chromatography. The concentrations (mean +/- SD) of the two diols in four normal males are: 213 +/- 111 pg/ml for the 3 alpha-diol and 246 +/- 133 pg/ml for the 3 beta-diol.

show abstract

Radioimmunoassay of 5-androstene-3β,17β-diol in plasma and in breast cyst fluid

Nahoul¹,

Bournique²,

Adeline³

et al. 1986

Journal of Steroid Biochemistry

View full text Add to dashboard Cite

Determination of 5α-androstane-3α,17β-diol and 5α-androstane-3β,17β-diol in human plasma by radioimmunoassay

Cited by 5 publications

References 14 publications

Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol

Prostate formation in a marsupial is mediated by the testicular androgen 5α-androstane-3α,17β-diol

Determination of 5α-androstane-3α, 17β-diol and 5α-androstane-3β, 17β-diol in human plasma by selected ion monitoring

Radioimmunoassay of 5-androstene-3β,17β-diol in plasma and in breast cyst fluid

Contact Info

Product

Resources

About